Nephros, Inc. (NASDAQ:NEPH) Short Interest Update

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 4,900 shares, a decline of 36.4% from the November 30th total of 7,700 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 11,400 shares, the days-to-cover ratio is currently 0.4 days.

Analyst Ratings Changes

Separately, Benchmark restated a “speculative buy” rating and set a $5.00 price target on shares of Nephros in a report on Tuesday, November 12th.

Nephros Stock Up 0.7 %

NEPH opened at $1.49 on Monday. The stock’s 50 day moving average price is $1.52 and its two-hundred day moving average price is $1.78. The firm has a market capitalization of $15.71 million, a P/E ratio of -16.56 and a beta of 1.21. Nephros has a 12-month low of $1.36 and a 12-month high of $4.04.

Institutional Investors Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP purchased a new position in Nephros, Inc. (NASDAQ:NEPH) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned about 0.17% of Nephros at the end of the most recent reporting period. Institutional investors own 41.10% of the company’s stock.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.